Masaru Matsuda
Consejero General en ARCUTIS BIOTHERAPEUTICS, INC. .
Fortuna: 2 M $ al 30/04/2024
Origen de la red de primer grado Masaru Matsuda.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 32 | |
| Public Company | Biotechnology | 21 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Masaru Matsuda a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Founder Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Administrative Officer Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
| KITE PHARMA INC | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Sales & Marketing | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
| MIRATI THERAPEUTICS | Biotechnology | Human Resources Officer Director of Finance/CFO Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer General Counsel | |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The company is based in Breda, Netherlands. | Medical Distributors | Corporate Officer/Principal Director of Finance/CFO | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Compliance Officer Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Doctorate Degree | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
Dompe Biotec SpA
 Dompe Biotec SpA Pharmaceuticals: MajorHealth Technology Dompe Biotec SpA (Dompé Biotec SpA) provides biotechnological drugs. Its products are used for the treatment of haematology, infectious diseases, nephrology, oncology, transfusion units and neuro-oncology. The company was founded in 1988 and is headquartered in Milan, Italy | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Chairman Director of Finance/CFO | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| CAREFUSION CORPORATION | Medical Distributors | Investor Relations Contact Human Resources Officer | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| University of California, Los Angeles | College/University | Undergraduate Degree Masters Business Admin | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| SYNEOS HEALTH, INC. | Biotechnology | Director/Board Member | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| VISTERRA INC | Pharmaceuticals: Major | Director/Board Member | |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Director of Finance/CFO | |
| TURG POIN | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| University of Glasgow | College/University | Doctorate Degree | |
| Pace University | College/University | Masters Business Admin | |
| Brooklyn College | College/University | Undergraduate Degree | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Royal College of Physicians & Surgeons of Glasgow
 Royal College of Physicians & Surgeons of Glasgow Other Consumer ServicesConsumer Services The Royal College of Physicians and Surgeons of Glasgow is a multidisciplinary organization that sets standards of care for the prevention and treatment of sickness and trauma in travelers. The British company has published a good practice guide for providing a travel health service, which defines the standards of care every practitioner should achieve in their practice of travel medicine for the health and safety of the international traveler. The organization offers a wide range of membership benefits and discounts on clinical and non-clinical skills courses, conferences, and e-learning. The private company also provides examinations and assessments across medical, surgical, and dental specialties to advance the profession and improve patient care through continuing professional development. | Other Consumer Services | Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 41 |
| Reino Unido | 5 |
| Irlanda | 3 |
| Países Bajos | 2 |
| Italia | 2 |
Sectorial
| Health Technology | 35 |
| Consumer Services | 12 |
| Distribution Services | 3 |
| Commercial Services | 3 |
| Finance | 2 |
Operativa
| Director/Board Member | 131 |
| Corporate Officer/Principal | 99 |
| Independent Dir/Board Member | 57 |
| Undergraduate Degree | 44 |
| Chief Tech/Sci/R&D Officer | 28 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Patrick Heron | 42 |
| Joseph Turner | 22 |
| Keith Leonard | 20 |
| John Smither | 20 |
| Kenneth Kelley | 19 |
| Halley Gilbert | 17 |
| Bhaskar Chaudhuri | 16 |
| Laurie Stelzer | 13 |
| Howard Welgus | 12 |
| Harry Leonhardt | 12 |
| Michael E. Paolucci | 10 |
| Terrie Curran | 10 |
| Elaine Sun | 10 |
| Bernadette Connaughton | 10 |
| Albert Kildani | 9 |
- Bolsa de valores
- Insiders
- Masaru Matsuda
- Conexiones Empresas
